Market Overview:
The global nonsteroidal anti-inflammatory drugs (NSAIDs) market is expected to register a CAGR of 5.8% during the forecast period, 2018-2030. The growth in the market can be attributed to factors such as rising prevalence of chronic diseases, increasing geriatric population, and growing demand for over-the-counter NSAIDs. Based on type, the global NSAIDs market is segmented into paracetamol, ibuprofen, aspirin, naproxen and others. Ibuprofen held the dominant position in 2017 and is expected to maintain its lead throughout the forecast period. This can be attributed to its high usage rates for pain relief across various applications such as hospital pharmacies, retail pharmacies and online pharmacies. Naproxen is projected to grow at a highest CAGR during the forecast period owing to its properties such as analgesic action and anti-inflammatory effects. On basis of application type hospitals pharmacies accounted for majority share in 2017 followed by retail pharmacies.
Product Definition:
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) are drugs that help to reduce inflammation. This can be helpful in treating conditions like arthritis, gout, and other types of pain. NSAIDs are important because they can help people to live more comfortably and without as much pain.
Paracetamol:
Paracetamol, also known as acetaminophen or APAP is a widely used over the counter (OTC) drug for pain and fever reduction. Paracetamol can be obtained both as a generic medicine and through brand name products such as Tylenol. It is one of the most commonly taken OTC medicines in the world with an estimated 90 million bottles sold each year globally.
Ibuprofen:
Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) and it's used for the treatment of pain. It works by blocking the production of prostaglandins, which causes pain. Ibuprofen itself has very little effect on pain; it works by decreasing the amount of prostaglandin produced in your body.
Application Insights:
The acute pain segment dominated the global nonsteroidal anti-inflammatory drugs (NSAIDs) market in 2017, accounting for 41.5% share of the overall revenue. The high share is attributable to rising prevalence of pain disorders and increasing number of hospital pharmacies dispensing these medicines. Acute pain includes toothache as well as headache, which occur at the same time and are not related to a specific cause. As per WHO, around 1 in 5 adults suffer from acute pains each year; however, only 1 in 10 cases are treated with medication due to lack of healthcare facilities or practitioners skilled in treating such conditions. Thus, an increase in availability and affordability of treatment is expected to drive demand over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to high consumer awareness and availability of a wide range of products with different prices. Asia Pacific is estimated to be the fastest-growing regional market from 2018 to 2030 owing to increasing product consumption in countries, such as China, India, Japan, and South Korea. Moreover, rising healthcare expenditure by governments along with an increase in disposable income will boost demand for NSAIDs over the forecast period.
The COVID-19 pandemic has had a significant impact on various industries across Asia Pacific including healthcare and pharmaceuticals sectors which are majorly dependent on exportations for their operations. Aspirin and paracetamol are among popular NSAIDs consumed across this region; however they witnessed a decline post COVID19 outbreak as consumers refrained from consuming any medication that could lead them into contact with others or cause harmlessly fatal infections like coronavirus (COVID 19).
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace and this is expected to drive the demand for NSAIDs in the coming years.
- Rising prevalence of chronic diseases: The prevalence of chronic diseases such as arthritis, cancer, and heart disease is on the rise and this is expected to boost the demand for NSAIDs in the near future.
- Growing awareness about NSAIDs: There has been a growing awareness about the benefits of using NSAIDs among consumers in recent years and this is likely to propel market growth over the forecast period.
- Technological advancements: The development of novel technologies that improve drug delivery has led to an increase in uptake of NSAIDs by consumers worldwide, thereby propelling market growth. 5) Availability of generic versions: A large number of generic versions are available for various types of NSAIDS drugs which has helped reduce their cost, making them more affordable for consumers
Scope Of The Report
Report Attributes
Report Details
Report Title
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Research Report
By Type
Paracetamol, Ibuprofen, Aspirin, Naproxen, Others
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Novartis, Pfizer, Boehringer Ingelheim, Teva Pharmaceutical, Hospira, Lonza Group, Mylan, Aurobindo Pharma, Dr. Reddy's Laboratories, Actavis, Wuxi Apptec, Zhejiang NHU
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
159
Number of Tables & Figures
112
Customization Available
Yes, the report can be customized as per your need.
Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Report Segments:
The global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market is segmented on the basis of:
Types
Paracetamol, Ibuprofen, Aspirin, Naproxen, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis
- Pfizer
- Boehringer Ingelheim
- Teva Pharmaceutical
- Hospira
- Lonza Group
- Mylan
- Aurobindo Pharma
- Dr. Reddy's Laboratories
- Actavis
- Wuxi Apptec
- Zhejiang NHU
Highlights of The Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Paracetamol
- Ibuprofen
- Aspirin
- Naproxen
- Others
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
NSAIDs are a type of medication that is used to reduce inflammation. They work by blocking the action of certain chemicals in the body that can cause pain and inflammation.
Some of the major players in the nonsteroidal anti-inflammatory drugs (nsaids) market are Novartis, Pfizer, Boehringer Ingelheim, Teva Pharmaceutical, Hospira, Lonza Group, Mylan, Aurobindo Pharma, Dr. Reddy's Laboratories, Actavis, Wuxi Apptec, Zhejiang NHU.
The nonsteroidal anti-inflammatory drugs (nsaids) market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size & Forecast, 2020-2028 4.5.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Y-o-Y Growth 4.5.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Paracetamol
5.2.2 Ibuprofen
5.2.3 Aspirin
5.2.4 Naproxen
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Paracetamol
9.6.2 Ibuprofen
9.6.3 Aspirin
9.6.4 Naproxen
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Paracetamol
10.6.2 Ibuprofen
10.6.3 Aspirin
10.6.4 Naproxen
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Paracetamol
11.6.2 Ibuprofen
11.6.3 Aspirin
11.6.4 Naproxen
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Paracetamol
12.6.2 Ibuprofen
12.6.3 Aspirin
12.6.4 Naproxen
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Paracetamol
13.6.2 Ibuprofen
13.6.3 Aspirin
13.6.4 Naproxen
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market: Competitive Dashboard
14.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis
14.3.2 Pfizer
14.3.3 Boehringer Ingelheim
14.3.4 Teva Pharmaceutical
14.3.5 Hospira
14.3.6 Lonza Group
14.3.7 Mylan
14.3.8 Aurobindo Pharma
14.3.9 Dr. Reddy's Laboratories
14.3.10 Actavis
14.3.11 Wuxi Apptec
14.3.12 Zhejiang NHU